
Cancer-Targeting Compound 1
CAS No. 1007581-62-5
Cancer-Targeting Compound 1( —— )
Catalog No. M33205 CAS No. 1007581-62-5
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 692 | Get Quote |
![]() ![]() |
5MG | 908 | Get Quote |
![]() ![]() |
10MG | 1226 | Get Quote |
![]() ![]() |
25MG | 1766 | Get Quote |
![]() ![]() |
50MG | 2383 | Get Quote |
![]() ![]() |
100MG | 3132 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCancer-Targeting Compound 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.
-
DescriptionCancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2.
-
In VitroCancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1007581-62-5
-
Formula Weight299.35
-
Molecular FormulaC15H13N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C)COC(=O)N1c1nc(cs1)-c1ccc(cc1)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.
molnova catalog



related products
-
TCS 1205
GABAA α2 agonist and GABAA α1 partial agonist.
-
Ladanein
Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays moderate (20-40 microM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines.
-
Tubeimoside II
Tubeimoside II(Tubeimoside-B) is a natural analogue of oleanane type of triterpenoid saponin; show anti-inflammatory, antitumor, and antitumor-promoting effects.